Page last updated: 2024-10-26

etodolac and Parodontosis

etodolac has been researched along with Parodontosis in 1 studies

Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tucker, PW1
Smith, JR1
Adams, DF1

Trials

1 trial available for etodolac and Parodontosis

ArticleYear
A comparison of 2 analgesic regimens for the control of postoperative periodontal discomfort.
    Journal of periodontology, 1996, Volume: 67, Issue:2

    Topics: Acetaminophen; Administration, Oral; Adult; Alveolectomy; Analgesics, Non-Narcotic; Analgesics, Opio

1996